LifeScience
Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, announced that it has entered into an e...
November 27, 2025 | News
eXmoor Pharma, the integrated cell and gene therapy CDMO with embedded consultancy expertise, and Royal Free London NHS Foundation Trust, throug...
November 27, 2025 | News
Exyte, a global leader in the design, engineering, and delivery of high-tech facilities, has completed the integration of Pharmaplan, marking the full tran...
November 26, 2025 | News
Beyfortus® (nirsevimab) is an available option designed to protect all infants – whether born full-term or pre-term, healthy or with underlying...
November 25, 2025 | News
GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, successfully hosted the GenScript Biotech Global Forum ...
November 24, 2025 | News
Aspen Neuroscience, Inc., a clinical-stage biotechnology company pioneering autologous regenerative therapies, announced the closing of a $115 millio...
November 21, 2025 | News
CRScube has announced the successful acquisition of Mednet, marking a key milestone in its global strategic growth and expansion into the North Ameri...
November 20, 2025 | News
Nona Biosciences, a global biotechnology company providing integrated solutions for biological drug discovery and development from I to I® (Idea t...
November 20, 2025 | News
At PEGS Europe 2025, one of the industry's premier gatherings for innovation in protein and antibody engineering, Tsingke Biotech highlighted its latest ac...
November 20, 2025 | News
YolTech Therapeutics, a clinical-stage biotechnology company developing next-generation in vivo gene editing therapies, today announced that the U.S. Food ...
November 20, 2025 | News
Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Resear...
November 19, 2025 | News
Partnership strengthens Bio-Techne's leadership in AI-enabled protein innovation NovoBody™ Duo molecules offer multi-specific binding capabilities...
November 19, 2025 | News
EPKINLY plus rituximab and lenalidomide (EPKINLY + R2) is now the first and only bispecific antibody combination therapy available f...
November 19, 2025 | News
Genesis MedTech Group and the National University Health System (NUHS) have formed a strategic partnership to advance artificial intelligence (AI...
November 19, 2025 | News
Most Read
Bio Jobs
News
Editor Picks